Pfizer's Prevnar prevents pneumonia in study of seniors, signaling broader use of vaccine
This article was originally published in Scrip
Executive Summary
Pfizer’s Prevnar worked to prevent pneumonia in a large study of older adults, signaling a potential for broader use of the company’s vaccine.